This is the reality: CV19 immunity won't last, the vaccines they're working on are from virions sampled months ago. Do The Math... LLMab will debut if not directly, then very shortly onto the WHO's Model List of Essential Medicines. Everyone will need a stockpile, but it'll be years before that can happen.

Maybe the buyout offers will increase to $30 per share by then. Kidding, of course